BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhu Y, Mi Y, Wang Z, Jia X, Jin Z. Norcantharidin inhibits viability and induces cell cycle arrest and apoptosis in osteosarcoma. Oncol Lett 2019;17:456-61. [PMID: 30655787 DOI: 10.3892/ol.2018.9615] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Wang L, Otkur W, Wang A, Wang W, Lyu Y, Fang L, Shan X, Song M, Feng Y, Zhao Y, Piao H, Qi H, Liu J. Norcantharidin overcomes vemurafenib resistance in melanoma by inhibiting pentose phosphate pathway and lipogenesis via downregulating the mTOR pathway. Front Pharmacol 2022;13:906043. [DOI: 10.3389/fphar.2022.906043] [Reference Citation Analysis]
2 Ye L, Xu Y, Wang L, Zhang C, Hu P, Tong S, Liu Z, Tian D. Downregulation of CYP2E1 is associated with poor prognosis and tumor progression of gliomas. Cancer Med 2021;10:8100-13. [PMID: 34612013 DOI: 10.1002/cam4.4320] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
3 Singh R, Cheng S, Li J, Kumar S, Zeng Q, Zeng Q. Norcantharidin combined with 2-deoxy-d-glucose suppresses the hepatocellular carcinoma cells proliferation and migration. 3 Biotech 2021;11:142. [PMID: 33708465 DOI: 10.1007/s13205-021-02688-w] [Reference Citation Analysis]
4 Pan MS, Cao J, Fan YZ. Insight into norcantharidin, a small-molecule synthetic compound with potential multi-target anticancer activities. Chin Med 2020;15:55. [PMID: 32514288 DOI: 10.1186/s13020-020-00338-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
5 Huang Z, Sun H, Lu Y, Zhao F, Liu C, Wang Q, Zheng C, Lu R, Song K. Strontium/Chitosan/Hydroxyapatite/Norcantharidin Composite That Inhibits Osteosarcoma and Promotes Osteogenesis In Vitro. Biomed Res Int 2020;2020:9825073. [PMID: 32076624 DOI: 10.1155/2020/9825073] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]